) into a pathological conformer (PrP

Sc
) is thought to be promoted of cells expressing soluble PrP C that lacks the GPI anchor (Horiuchi and Caughey, 1999 
Conditional Expression of a Soluble PrP Dimer in Transgenic Mice
Tg550Њ mice were healthy at Ͼ450 days post inoculation (dpi) by the ip or ic route, whereas all Prnp ϩ/ϩ mice We expressed PrP-Fc 2 within a vector encompassing the murine Prnp locus . We fused (129/Sv ϫ C57BL/6) succumbed to scrapie at Յ206 dpi (Figures 2A and 2B ). Inoculated transgenic animals were the Prnp coding region (lacking the carboxy terminal GPI attachment signal) to the Fc portion of a human sacrificed, and tissues were analyzed by immunoblotting. No traces of prion protein were detected in brains IgG 1 heavy chain. The binding sites for Fc␥ receptors and for complements were inactivated by mutagenesis and spleens after PK digestion, even when PrP Sc was concentrated by sodium phosphotungstate (PTA) pre- (Ettinger et al., 1996) ; this is important since complementary components influence prion pathogenesis (Klein et cipitation ( in scrapie-inoculated tg550Њ mice was assessed by ic inoculation of 3 mg brain homogenate (taken at 450 dpi) Six founder mice were generated and denominated Prnp tm1 -Tg(PrP/FcStop)Zbz, from which two lines, tg550 to four tga20 indicator mice. None of the indicator mice developed scrapie at Ն150 dpi ( Figure 1C ). Under reducing conditions, antibodies to PrP and to human Fc␥ 1 We then investigated whether PrP-Fc 2 can act as a modifier of prion disease. We backcrossed tg550Њ and tg588Њ detected bands of 50-65 kDa in transgenic brains (Figure 1D ). This is half the size of the bands seen under mice twice with C57BL/6 mice in order to express PrPFc 2 along with endogenous PrP C . The resulting mice nonreducing conditions. Therefore, PrP-Fc 2 exists as a dimer in vivo. PNGase F digestion, which removes (designated tg550 ϩ and tg588 ϩ ) were inoculated ic or ip with a saturating (3 ϫ 10 5 or 3 ϫ 10 6 LD 50 units, glycans, shifted the reduced PrP-Fc band to a major moiety with the expected molecular weight of 55 kDa respectively) or a limiting (3 ϫ 10 2 or 3 ϫ 10 3 LD 50 units, respectively) prion inoculum, and the incubation time to and to a minor band of 40 kDa. The minor band was not detected by an anti-N-terminal PrP antibody (data not terminal disease was determined. Typical symptoms of scrapie, including ataxia and kyphosis, occurred in all shown), suggesting that it represents a carboxy terminal cleavage product. prion-inoculated tg550 ϩ and wt mice. However, expression of the transgene delayed onset of disease by 80-We compared the concentration of PrP-Fc 2 to endogenous PrP C in brain and spleen by quantitative Western 120 days, depending on dose and route of inoculation in tg550 ϩ . After ip inoculation, all prion-inoculated tg588 ϩ analysis (Heppner et al., 2001 ). Brain PrP-Fc 2 was expressed approximately 12-and 10-fold less than PrP C mice were still alive and healthy at the time of writing in tg550 and tg588 brains, respectively; in spleen, PrP-(Ͼ300 dpi). After ic inoculation, two mice succumbed Fc 2 expression was 4-fold less than PrP C in tg550 but to disease at 240 and 257 dpi, and two mice were still 1.5-fold more in tg588 (data not shown). Therefore, PrPalive (Ͼ280) (Figures 2A and 2B . We found that this process is antagonized by PrP-Fc 2 . Prion titers in nervous system (CNS) and spleen.
In parallel, we determined prion titers in brains and spleens of wt mice harvested at 48 dpi after ip inoculation reached 4.2-4.9 logLD 50 /g, which corresponds to spleens at 48 and 102 dpi by bioassay with tga20 mice (Fischer et al., 1996). While brains of wt mice contained the maximal levels typically reached in lymphoreticular organs. Remarkably, tg588 ϩ spleens contained no deprion titers of 3.5-4 log LD 50 /g tissue at 48 days after ic inoculation, infectivity in tg550 ϩ brains was undetecttectable infectivity (Table 1 ). The tg550 ϩ spleens had 1-2.5 log less infectivity than wt spleens (Table 1 ). Thereable or barely detectable. At 102 dpi, however, prion titers in tg550 ϩ brains were about to catch up, being fore, PrP-Fc 2 is a potent antagonist of prion replication not only within the CNS, but also in lymphoreticular only 0.5 log 10 units lower than wt controls (Table 1 ), yet titers in tg588 ϩ brains were still Ն2.5 log 10 units less organs. We formally exclude that diminished or blocked lymphoreticular prion accumulation may be due to imthan wt (Table 1) .
Following ip inoculation, prions colonize the lymphopaired "wash-back" of brain infectivity, since no prions Figure 4E ). Instead, when we order to reduce the concentration of chaotropic salts to mixed scrapie-sick wt brain extract with up to 500 g a level that was previously determined not to denature uninfected StopPrP-Fc brain homogenate, no or trace PrP Sc and not to interfere with binding to PrP-Fc 2 (data amounts of PrP Sc were detected, confirming the specificnot shown). Chaotrope-treated homogenate was then ity of the assay system ( Figure 4E hypothesis. It will be interesting to explore whether imtion after infection, whereas it displayed low buoyancy munolocalizatory methods can be used to trace localizain noninfected mice. 
